FMIL vs. LLY

Last updated Apr 1, 2026

Compare and contrast key facts about Fidelity New Millennium ETF (FMIL) and Eli Lilly and Company (LLY).

FMIL is an actively managed fund by Fidelity. It was launched on Jun 3, 2020.

Performance

FMIL vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity New Millennium ETF (FMIL) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

FMIL vs. LLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
FMIL Fidelity New Millennium ETF	-3.67%	17.67%	27.89%	25.07%	-0.04%	24.53%	18.76%
LLY Eli Lilly and Company	-14.27%	40.25%	33.30%	60.91%	34.26%	66.08%	13.15%

Returns By Period

In the year-to-date period, FMIL achieves a -3.67% return, which is significantly higher than LLY's -14.27% return.

FMIL

• 1D: 3.48%
• 1M: -5.49%
• YTD: -3.67%
• 6M: -0.80%
• 1Y: 19.26%
• 3Y*: 19.56%
• 5Y*: 14.40%
• 10Y*: —

LLY

• 1D: 3.74%
• 1M: -12.57%
• YTD: -14.27%
• 6M: 20.93%
• 1Y: 12.19%
• 3Y*: 39.90%
• 5Y*: 39.16%
• 10Y*: 30.92%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

FMIL vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FMIL

FMIL Risk / Return Rank: 66
FMIL Sharpe Ratio Rank: 61
FMIL Sortino Ratio Rank: 63
FMIL Omega Ratio Rank: 65
FMIL Calmar Ratio Rank: 67
FMIL Martin Ratio Rank: 72

LLY

LLY Risk / Return Rank: 51
LLY Sharpe Ratio Rank: 53
LLY Sortino Ratio Rank: 48
LLY Omega Ratio Rank: 49
LLY Calmar Ratio Rank: 53
LLY Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FMIL vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity New Millennium ETF (FMIL) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	FMIL	LLY	Difference
Sharpe ratio Return per unit of total volatility	1.04	0.29	+0.75
Sortino ratio Return per unit of downside risk	1.55	0.69	+0.86
Omega ratio Gain probability vs. loss probability	1.23	1.10	+0.14
Calmar ratio Return relative to maximum drawdown	1.65	0.42	+1.23
Martin ratio Return relative to average drawdown	7.14	1.02	+6.11
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

FMIL vs. LLY - Sharpe Ratio Comparison

The current FMIL Sharpe Ratio is 1.04, which is higher than the LLY Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of FMIL and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	FMIL	LLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.04	0.29	+0.75
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.85	1.23	-0.37
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.04	—
Sharpe Ratio (All Time) Calculated using the full available price history	1.04	0.56	+0.48

Correlation

The correlation between FMIL and LLY is 0.31, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

FMIL vs. LLY - Dividend Comparison

FMIL's dividend yield for the trailing twelve months is around 1.14%, more than LLY's 0.68% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
FMIL Fidelity New Millennium ETF	1.14%	1.10%	0.82%	0.57%	1.67%	1.68%	0.89%	0.00%	0.00%	0.00%	0.00%	0.00%
LLY Eli Lilly and Company	0.68%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%

Drawdowns

FMIL vs. LLY - Drawdown Comparison

The maximum FMIL drawdown since its inception was -19.72%, smaller than the maximum LLY drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for FMIL and LLY.

Drawdown Indicators

	FMIL	LLY	Difference
Max Drawdown Largest peak-to-trough decline	-19.72%	-68.24%	+48.52%
Max Drawdown (1Y) Largest decline over 1 year	-11.92%	-30.26%	+18.34%
Max Drawdown (5Y) Largest decline over 5 years	-19.72%	-34.48%	+14.76%
Max Drawdown (10Y) Largest decline over 10 years	—	-34.48%	—
Current Drawdown Current decline from peak	-6.85%	-17.00%	+10.15%
Average Drawdown Average peak-to-trough decline	-3.05%	-19.25%	+16.20%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.76%	12.39%	-9.63%

Volatility

FMIL vs. LLY - Volatility Comparison

The current volatility for Fidelity New Millennium ETF (FMIL) is 6.13%, while Eli Lilly and Company (LLY) has a volatility of 9.04%. This indicates that FMIL experiences smaller price fluctuations and is considered to be less risky than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	FMIL	LLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.13%	9.04%	-2.91%
Volatility (6M) Calculated over the trailing 6-month period	10.24%	26.21%	-15.97%
Volatility (1Y) Calculated over the trailing 1-year period	18.67%	42.44%	-23.77%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	16.94%	32.14%	-15.20%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	17.78%	29.80%	-12.02%